Scoliosis in Fibrous Dysplasia/McCune‐Albright Syndrome: Factors Associated With Curve Progression and Effects of Bisphosphonates

• Published in: Journal of bone and mineral research Vol. 33; no. 9; pp. 1641 - 1648
• Main Authors: Berglund, Jason A, Tella, Sri Harsha, Tuthill, Kaitlyn F, Kim, Lauren, Guthrie, Lori C, Paul, Scott M, Stanton, Robert, Collins, Michael T, Boyce, Alison M
• Format: Journal Article
• Language: English
• Published: United States Oxford University Press 01.09.2018
• Subjects: ANTIRESORPTIVES; Bisphosphonates; Bone turnover; CANCER; Endocrine disorders; Fibroblast growth factor 23; Fibrous dysplasia; Hip; Hyperthyroidism; Hypophosphatemia; IMPLANTS; Leg; Lung diseases; ORTHOPAEDICS; Osteocalcin; PRIMARY TUMORS OF BONE AND CARTILAGE; Radiography; Risk factors; Scoliosis; THERAPEUTICS; United States > US; THERAPEUTICS; ORTHOPAEDICS; IMPLANTS; CANCER; ANTIRESORPTIVES; PRIMARY TUMORS OF BONE AND CARTILAGE

ABSTRACT Scoliosis is a complication of fibrous dysplasia/McCune‐Albright syndrome (FD/MAS); however, risk factors and long‐term outcomes are unknown. Bisphosphonates are commonly used; however, it is unknown whether their use decrease the risk of progressive scoliosis. Clinical data from the Nation...